Role of mammalian target of rapamycin (mTOR) signalling in oncogenesis
- PMID: 37028545
- DOI: 10.1016/j.lfs.2023.121662
Role of mammalian target of rapamycin (mTOR) signalling in oncogenesis
Abstract
The signalling system known as mammalian target of rapamycin (mTOR) is believed to be required for several biological activities involving cell proliferation. The serine-threonine kinase identified as mTOR recognises PI3K-AKT stress signals. It is well established in the scientific literature that the deregulation of the mTOR pathway plays a crucial role in cancer growth and advancement. This review focuses on the normal functions of mTOR as well as its abnormal roles in cancer development.
Keywords: Apoptosis; Pathological angiogenesis; Rapamycin and rapalogues; Signalling cascade; mTOR.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination.Development. 2016 Sep 1;143(17):3050-60. doi: 10.1242/dev.137075. Development. 2016. PMID: 27578176 Review.
-
New inhibitors of the mammalian target of rapamycin signaling pathway for cancer.Expert Opin Investig Drugs. 2010 Aug;19(8):919-30. doi: 10.1517/13543784.2010.499121. Expert Opin Investig Drugs. 2010. PMID: 20569080 Review.
-
Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor.Mol Cancer Ther. 2009 May;8(5):1157-68. doi: 10.1158/1535-7163.MCT-08-1008. Epub 2009 May 5. Mol Cancer Ther. 2009. PMID: 19417153
-
Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway.Oncotarget. 2016 Sep 6;7(36):58381-58395. doi: 10.18632/oncotarget.11126. Oncotarget. 2016. PMID: 27517315 Free PMC article.
-
A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.BJU Int. 2012 Dec;110(11 Pt C):E1237-48. doi: 10.1111/j.1464-410X.2012.11569.x. Epub 2012 Oct 29. BJU Int. 2012. PMID: 23107319
Cited by
-
The Role of mTOR in the Doxorubicin-Induced Cardiotoxicity: A Systematic Review.Cell Biochem Biophys. 2024 Aug 5. doi: 10.1007/s12013-024-01475-7. Online ahead of print. Cell Biochem Biophys. 2024. PMID: 39102090 Review.
-
In vivo evaluation of mebendazole and Ran GTPase inhibition in breast cancer model system.Nanomedicine (Lond). 2024;19(12):1087-1101. doi: 10.2217/nnm-2023-0351. Epub 2024 Apr 25. Nanomedicine (Lond). 2024. PMID: 38661720
-
Anticancer potential of phytochemicals derived from mangrove plants: Comprehensive mechanistic insights.Food Sci Nutr. 2024 Jul 10;12(9):6174-6205. doi: 10.1002/fsn3.4318. eCollection 2024 Sep. Food Sci Nutr. 2024. PMID: 39554337 Free PMC article. Review.
-
Microarray Analysis of Visceral Adipose Tissue in Obese Women Reveals Common Crossroads Among Inflammation, Metabolism, Addictive Behaviors, and Cancer: AKT3 and MAPK1 Cross Point in Obesity.J Obes. 2024 Oct 24;2024:4541071. doi: 10.1155/2024/4541071. eCollection 2024. J Obes. 2024. PMID: 39484291 Free PMC article.
-
Pharmacological effects and mechanisms of paeonol on antitumor and prevention of side effects of cancer therapy.Front Pharmacol. 2023 Jun 20;14:1194861. doi: 10.3389/fphar.2023.1194861. eCollection 2023. Front Pharmacol. 2023. PMID: 37408762 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous